Cross-Plant Monitoring Model Transfer for Fed-Batch mAb Production under Limited Target Data
Authors:
- 19 October 2026
- journal article
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 65 (42) , 22590-22615
Abstract
Establishing reliable multivariate statistical process monitoring (MSPM) after transfer of a biopharmaceutical process is difficult when only a few normal target-site batches and no labeled faulty batches are available. This work contributes to addressing two key challenges in biopharmaceutical manufacturing: (i) developing a reduced first-principles simulator for two industrial 2000 L fed-batch monoclonal-antibody processes and (ii) transferring MSPM models between source and target plants that, while similar in scale, differ in operating conditions, batch recipes, configurations, and sensor systems. The simulator couples cell-population kinetics, reaction-informed effective metabolite rates, gas–liquid mass transfer, acid–base chemistry, prescribed feed events, and pH and dissolved-oxygen control. Its effective coefficients were calibrated against industrial trajectories and frozen before held-out, batch-conditioned validation; it is used as a fit-for-purpose engineering scenario generator rather than as a uniquely identified mechanistic digital twin. We next develop recursive principal component analysis (RPCA) transfer variants for the few-target-batch setting and evaluate four strategies as completed target batches become available. Site-wise target scaling can amplify near-zero cross-batch variance in plateau- and control-dominated regions, whereas source-anchored variance shrinkage stabilizes this failure mode. Because the trajectories are nonstationary, autocorrelated, and non-Gaussian, we replace global, time-invariant parametric F and χ2 limits with empirical, within-batch-time-resolved Hotelling’s T2 and squared prediction error (SPE) limits. Process monitoring approaches are compared using measured normal histories and a common set of simulated normal and engineering-defined fault cases; paired evaluations show that source-anchored shrinkage and pooled scaling provide the leading scarce-target-data trade-off, chiefly through improved false-alarm control while preserving fault sensitivity.Keywords
Funding Information
- GlaxoSmithKline (BIDS3000039409)
This publication has 63 references indexed in Scilit:
- A carbon dioxide stripping model for mammalian cell culture in manufacturing scale bioreactorsBiotechnology and Bioengineering, 2017
- Process model comparison and transferability across bioreactor scales and modes of operation for a mammalian cell bioprocessBiotechnology Progress, 2012
- Robust parameter estimation during logistic modeling of batch and fed‐batch culture kineticsBiotechnology Progress, 2009
- Multivariate monitoring of batch processes using batch‐to‐batch informationAIChE Journal, 2004
- Product transfer between plants using historical process dataAIChE Journal, 2000
- Monitoring batch processes using multiway principal component analysisAIChE Journal, 1994
- Estimation of dissolved carbon dioxide concentrations in aerobic fermentationsAIChE Journal, 1991
- Kinetic study of hybridoma cell growth in continuous culture. I. A model for non‐producing cellsBiotechnology and Bioengineering, 1991
- Kinetic modelling of hybridoma cell growth and immunoglobulin production in a large‐scale suspension cultureBiotechnology and Bioengineering, 1988
- A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate, and pHBiotechnology and Bioengineering, 1988